Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Nutrients ; 7(11): 8939-51, 2015 Oct 29.
Article in English | MEDLINE | ID: mdl-26529006

ABSTRACT

BACKGROUND: The importance of prebiotics consumption is increasing all over the world due to their beneficial effects on health. Production of better prebiotics from endemic plants raises possibilities to enhance nutritional effects in vulnerable population groups. Fructans derived from Agave Plant have demonstrated their safety and efficacy as prebiotics in animal models. Recently, the safety in humans of two fructans obtained from Agave tequilana (Metlin(®) and Metlos(®)) was demonstrated. METHODS: This study aimed to demonstrate the efficacy as prebiotics of Metlin(®) and Metlos(®) in newborns of a randomized, double blind, controlled trial with a pilot study design. Biological samples were taken at 20 ± 7 days, and three months of age from healthy babies. Outcomes of efficacy include impact on immune response, serum ferritin, C-reactive protein, bone metabolism, and gut bacteria changes. RESULTS: There were differences statistically significant for the groups of infants fed only with infant formula and with formula enriched with Metlin(®) and Metlos(®). CONCLUSIONS: Our results support the efficacy of Metlin(®) and Metlos(®) as prebiotics in humans, and stand the bases to recommend their consumption. TRIAL REGISTRATION: ClinicalTrials.gov, NCT 01251783.


Subject(s)
Agave/chemistry , Fructans/pharmacology , Health Status , Infant Formula/chemistry , Plant Extracts/pharmacology , Prebiotics , Bone and Bones/drug effects , Bone and Bones/metabolism , C-Reactive Protein/metabolism , Female , Ferritins/blood , Gastrointestinal Microbiome/drug effects , Humans , Immunity/drug effects , Infant, Newborn , Male , Mexico , Pilot Projects , Reference Values , Treatment Outcome
2.
Rev Invest Clin ; 65(6): 483-90, 2013.
Article in English | MEDLINE | ID: mdl-24687355

ABSTRACT

RATIONALE: Infant formulae are being supplemented with probiotics, prebiotics, or symbiotic despite uncertainties regarding their efficacy. Mexican agave is an interesting source of fructans with particular features and with potential prebiotic effects. MATERIAL AND METHODS: RCT in 600 healthy term babies (20 ± 7 days), allocated to receive standard infant formula (control) or infant formula added with a dual prebiotic system "Metlin® and Metlos®", from Mexican agave. Primary outcomes include stools frequency, stools consistency, gastrointestinal intolerance (frequency of abdominal distension, flatulency, regurgitations, vomiting). Secondary outcomes include changes on weight and height along the study and frequency of dermatologic problems (eczema). RESULTS: In 66,120 days of total follow-up, there were no differences on the frequency of stools passage (Human Milk: 3.8 ± 2.4 evacuations per day; Pro + Metlin + Metlos 3.6 ± 2.0; Pro + Metlin 3.6 ± 2; only Pro 3.4 ± 2.3¸ only formula 3.4 ± 2.0; p NS). Consistency of stools was similar between human milk and prebiotics supplemented groups. Also the frequency of gastrointestinal symptoms was significantly low between these groups. CONCLUSIONS: Fructans derivate from agave and added to infant formula are safe and well tolerated by Mexican healthy term babies.


Subject(s)
Agave , Fructans/adverse effects , Gastrointestinal Diseases/chemically induced , Growth Disorders/chemically induced , Infant Food/adverse effects , Plant Extracts/adverse effects , Prebiotics/adverse effects , Body Height/drug effects , Body Weight/drug effects , Defecation/drug effects , Diarrhea, Infantile/chemically induced , Female , Flatulence/chemically induced , Follow-Up Studies , Fructans/administration & dosage , Fructans/isolation & purification , Humans , Infant, Newborn , Male , Milk, Human , Plant Extracts/administration & dosage , Plant Extracts/pharmacology , Vomiting/chemically induced , Weight Gain/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...